HER2-positive breast cancer: What is it? - Mayo Clinic
Apr 9, 2024 · HER2-positive breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2). This protein promotes the growth of …
Breast cancer types: What your type means - Mayo Clinic
Oct 31, 2024 · HER2 positive. Breast cancer cells that make a lot of extra HER2 protein are called HER2 positive. Targeted therapy treatments with medicine that hurts cells making too much …
Recurrent breast cancer - Symptoms and causes - Mayo Clinic
Apr 19, 2024 · If your cancer makes extra HER2 protein, drugs that target that protein can help decrease the chance of the cancer recurring. Bone-building drugs. Taking bone-building drugs …
Vaccine study for HER2-positive breast cancer moves forward
Mar 1, 2019 · Trastuzumab works by activating the immune system's B cells, which look for and attack breast tumor cells with HER2 proteins on the surface. The new vaccine also stimulates …
Cáncer de mama positivo para HER2: ¿qué es? - Mayo Clinic
Apr 9, 2024 · HER2 no se hacen en forma rutinaria para carcinoma in situ del conducto, excepto cuando es parte de un ensayo clínico. Cada vez que el cáncer de mama recurre o se …
Trastuzumab (intravenous route) - Mayo Clinic
Aug 1, 2024 · Trastuzumab injection is also used in combination with cisplatin and capecitabine or 5-fluorouracil to treat HER2-overexpressing metastatic (cancer that has spread) stomach and …
Chemotherapy for breast cancer - Mayo Clinic
Jan 10, 2025 · HER2-positive breast cancer; Triple-negative breast cancer; High-grade breast cancers; Cancers that have spread to the lymph nodes; Larger breast cancers; Chemotherapy …
Recurrent breast cancer - Diagnosis and treatment - Mayo Clinic
Apr 19, 2024 · If testing shows your cancer cells produce excess HER2 protein, medications that target that protein will likely be recommended. Treating a regional recurrence. Treatments for …
Invasive lobular carcinoma - Diagnosis and treatment - Mayo Clinic
Jun 26, 2024 · HER2 is a protein that some healthy breast cells make. Some breast cancer cells develop changes that cause them to make a lot of extra HER2. Treatments can target the cells …
Breast cancer staging - Mayo Clinic
Feb 12, 2022 · Whether your cancer cells have a gene mutation that causes them to make excess HER2 protein Results of gene expression profiling tests (Oncotype DX, MammaPrint, others) …